72.2
Larimar Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
121
FY23:
90.2
FY24:
195
FY25:
142
(positive)
Change from FY21 to FY25
millions USD
FY21:
6.46
FY22:
5.67
FY23:
5.76
FY24:
4.92
FY25:
3.82
Total assets
Change from FY21 to FY25
millions USD
FY21:
78.7
FY22:
126
FY23:
95.9
FY24:
200
FY25:
146
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.85
FY22:
10.7
FY23:
9.51
FY24:
24.4
FY25:
64.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.41
FY22:
4.80
FY23:
4.71
FY24:
4.06
FY25:
2.96
(positive)
Change from FY21 to FY25
millions USD
FY21:
64.4
FY22:
111
FY23:
81.7
FY24:
172
FY25:
78.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
78.7
FY22:
126
FY23:
95.9
FY24:
200
FY25:
146
All amounts in millions USD